News
Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
The most important philosophy we have of AI is that AI will never make decisions. Period. So AI would help us collect the ...
This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...
Signing into law the other criminal justice bill, named the Law and Order Act, Stein praised the effort by lawmakers to ...
Explore more
CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...
CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it ...
CVS Health and its subsidiaries have experienced a turbulent week in the courts. | Not long after the state of Louisiana sued ...
The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should see earnings gains through the end of the decade.
A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for ...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results